PTC THERAPEUTICS, INC. (PTCT)
Pharmaceutical Preparations · Healthcare · $6.1B
Intrinsic Value (Consensus)
$121.49
Current Price
$73.27
Margin of Safety
+65.8%
65.8% Below Intrinsic Value
Value: $121
Price: $73
Valuation Model Estimates
Current Price: $73.27
DCF (Discounted Cash Flow)
$133.34
Graham Number
Not applicable
—
Earnings Power Value
$75.53
Relative Value (P/E)
$155.60
Dividend Discount Model
Not applicable
—
Consensus Value
$121.49
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
65
Profitability
10/25
Strength
17/25
Valuation
22/25
Growth
16/25
Financial Health Signals
High free cash flow yield (11.6%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $7.78
- EPS (Forward)
- $8.17
- Book Value
- $-2.48
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- N/A
- Debt/Equity
- —
- Revenue Growth
- 114.5%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance